Tracheostomy during <scp>SARS‐CoV</scp>‐2 pandemic: Recommendations from the New York Head and Neck Society

Miles, Brett A.; Schiff, Bradley A.; Ganly, Ian; Ow, Thomas J.; Cohen, Erik G.; Genden, Eric M.; Culliney, B.; Mehrotra, Bhoomi; Savona, Steven; Wong, Richard J.; Haigentz, Missak; Caruana, Salvatore M.; Givi, Babak; Patel, Kepal N.; Hu, Kenneth H.

doi:10.1002/hed.26166

Cited by 88 publications

(111 citation statements)

References 48 publications

Supporting

Mentioning

104

Contrasting

Unclassified

Order By: Relevance

“…As the number of patients infected by SARS-CoV-2 around the world is increasing, the demand for endotracheal intubation and invasive mechanical ventilatory support secondary to acute respiratory failure is increasing accordingly [9,10], which will certainly lead to an increase in tracheostomy in the following days [1]. Our study described the clinical characteristics and outcomes of COVID-19 patients who underwent tracheostomies, comprising 80 patients from 23 hospitals in Hubei Province, China.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Tracheostomy in 80 COVID-19 patients: a multicenter, retrospective, observational study

Tang

Zhu

et al. 2020

Preprint

View full text Add to dashboard Cite

The aim of our study was to describe the clinical characteristics and outcomes of patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia who underwent elective tracheostomies. We investigated all COVID-19 patients who underwent elective tracheostomies in intensive care units (ICUs) of 23 hospitals in Hubei Province, China, from January 8, 2020 to March 25, 2020. Demographic information, clinical characteristics, treatment, details of the tracheostomy procedure, successful weaning after tracheostomy, and living status were collected and analyzed. A total of 80 patients were included. The median duration from endotracheal intubation to tracheostomy was 17.5 [IQR 11.3-27.0] days. Most tracheotomies were performed by ICU physicians (62 (77.5%)) and using percutaneous techniques (63 (78.8%)) at the ICU bedside (76 (95.0%)). At 60 days after intubation, 31 (38.8%) patients experienced successful weaning from the ventilator, 17 (21.2%) patients were discharged from the ICU, and 43 (53.8%) patients had died. Higher 60-day mortality (22 (73.3%) vs 21 (42.0%)) was identified in patients who underwent early tracheostomy. In patients with SARS-CoV-2 pneumonia, tracheostomies were feasible to conduct by ICU physicians at bedside with few major complications. However, tracheostomies within 14 days of endotracheal intubation should be avoided.

show abstract

Section: Discussionmentioning

confidence: 99%

“…The novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a worldwide pandemic and a large and increasing number of patients who are critically ill and require endotracheal intubation and mechanical ventilation [1][2][3].…”

Section: Introductionmentioning

confidence: 99%

Tracheostomy in 80 COVID-19 patients: a multicenter, retrospective, observational study

Tang

Zhu

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Thus, the adjustment range is shown. In reference to [ 21 ] the PIP should be less than 30 mbar. The position of the piston screw was also documented to calculate the sensitivity to regulate the PIP.…”

Section: Resultsmentioning

confidence: 99%

Design and construction of a simplified, gas-driven, pressure-controlled emergency ventilator

Szlosarek

Teichert

Wetzel

et al. 2021

African Journal of Emergency Medicine

View full text Add to dashboard Cite

Introduction Due to the COVID-19 crisis or any other mass casualty situation it might be necessary to give artificial ventilation to many affected patients. Contrarily, the worldwide availability of emergency ventilators is still a shortage, especially in developing countries. Methods Modes of artificial ventilation were compared and the most safe, easy to use, and lung protecting principle was optimized to fit all requirements of both emergency ventilation and cost-effective mass production. Results The presented research results describe a simplified device for a pressure-controlled ventilation which works without electricity according to a known principle. Just pressurized gas and a patient connection is required. The device enables the control of basic ventilator parameters such as peak inspiratory pressure, positive end-expiratory pressure and the ventilation frequency. Further, the device is semiadaptive to the patient's lung stiffness and automatically maintains minute volume through frequency adjustment. The machine can be manufactured by turning, milling and drilling and needs purchased components with costs less than 100 USD. A sterilization and thus a reuse is possible. Discussion The presented development does not describe a ready-to-purchase ventilator, it rather outlines a refined working principle for emergency ventilation and its easiest methods of production with a minimum of requirements. The presented research aims on providing an open-source guideline for production of an emergency ventilator using worldwide available methods and thus should inspire local researchers to do a reverse engineering and eventually to put it into operation following country-specific regulations. For long-term ventilation exceeding emergency purposes, a monitoring of alarms for disconnection and violation of desired ventilator parameters should be established. The ventilator is limited to a fixed ratio between PIP and PEEP. Moreover, the ventilation frequency depends on two parameters, which needs some training. Nevertheless, the ventilator provides basic features to enable an emergency ventilation with minimal prerequisites.

show abstract

“…COVID-19 sonrası yayımlanan bazı rehberler (Amerika Birleşik Devletleri, İngiltere ve Kanada KBB uzmanlık derneklerinin rehberleri) ve 2003 yılındaki SARS tecrübesi trakeostomi işleminin entübasyondan 14 gün ve sonrasına ertelenmesini önermektedir. [18][19][20][21] Böylece hastada viral yük ve bulaştırma riski azalmakta, hastalığın seyri ve prognozu belirginleşmektedir.…”

Section: Trakeostomi Zamanlamasiunclassified

Tracheostomy Applications in Critically-Ill COVID-19 Patients

Aygencel¹,

Kemaloğlu²

2020

KBB ve BBC Dergisi

View full text Add to dashboard Cite

Çin'in Hubei eyaletine bağlı Wuhan kentinde Aralık 2019 tarihinde ortaya çıkan ve kısa sürede tüm dünyaya yayılarak bir salgın hâline dönüşen yeni tip şiddetli akut solunum sendromu-koronavirüs-2 [severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)]'nin dünya genelinde bulaştığı kişi sayısı 4.338.659'e, hayatını kaybeden hasta sayısı da 297.119 kişiye ulaşmıştır. 1,2 Türkiye'de ilk kez 11 Mart 2020 tarihinde tespit edilen bu virüs ile enfekte kişi sayısı 146.457'ye, ölen hasta sayısı da 4055'e yükselmiştir. 3

show abstract

Tracheostomy during SARS‐CoV‐2 pandemic: Recommendations from the New York Head and Neck Society

Cited by 88 publications

References 48 publications

Tracheostomy in 80 COVID-19 patients: a multicenter, retrospective, observational study

Tracheostomy in 80 COVID-19 patients: a multicenter, retrospective, observational study

Design and construction of a simplified, gas-driven, pressure-controlled emergency ventilator

Tracheostomy Applications in Critically-Ill COVID-19 Patients

Contact Info

Product

Resources

About